Clinical Trial Update: Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral gemifloxacin to intravenous cefotaxime for spontaneous bacterial peritonitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Cefotaxime (Cefotaxime)
• Gemifloxacin (gemifloxacin)

Snippet

Sponsor: Tanta University | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: RECRUITING